chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypotension, Insulin therapy, Lung consolidation, Lung infiltration, Lung opacity
Clinical narrative: Father found patient unresponsive at his home on 4/15.  Patients transported to ED via EMS.  Patient was in DKA, AKI, hypotensive and in respiratory distress.  Patient was started on high flow oxygen, insulin infusion, given saline boluses per sepsis protocol and started on cefepime, metronidazole,  iv vancomycin.  CRX showed diffuse pulmonary opacities appears to be moderate pulmonary edema, heart appears enlarged.  CT chest cardiomegaly,  bilateral infiltrates with consolidation at lung bases.  On 4/16 US extremities -occlusive thrombus in l popliteal vein and partially occlusive thrombus in L posterior tibial vein.  Echocardiogram -large pulmonary embolism in pulmonary artery. Vascular surgery was consulted to place a hemodialysis catheter (prior to alteplase administration).  Patient went into cardiopulmonary arrest as this procedure was started.  Patient was intubated, ACLS protocol followed, alteplase 50mg x 2 administered.  Patient expired.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Platelet count normal, Pulmonary embolism, Pulmonary oedema, Respiratory distress, Thrombolysis
Clinical narrative: Father found patient unresponsive at his home on 4/15.  Patients transported to ED via EMS.  Patient was in DKA, AKI, hypotensive and in respiratory distress.  Patient was started on high flow oxygen, insulin infusion, given saline boluses per sepsis protocol and started on cefepime, metronidazole,  iv vancomycin.  CRX showed diffuse pulmonary opacities appears to be moderate pulmonary edema, heart appears enlarged.  CT chest cardiomegaly,  bilateral infiltrates with consolidation at lung bases.  On 4/16 US extremities -occlusive thrombus in l popliteal vein and partially occlusive thrombus in L posterior tibial vein.  Echocardiogram -large pulmonary embolism in pulmonary artery. Vascular surgery was consulted to place a hemodialysis catheter (prior to alteplase administration).  Patient went into cardiopulmonary arrest as this procedure was started.  Patient was intubated, ACLS protocol followed, alteplase 50mg x 2 administered.  Patient expired.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ultrasound Doppler abnormal, Unresponsive to stimuli, Venous occlusion
Clinical narrative: Father found patient unresponsive at his home on 4/15.  Patients transported to ED via EMS.  Patient was in DKA, AKI, hypotensive and in respiratory distress.  Patient was started on high flow oxygen, insulin infusion, given saline boluses per sepsis protocol and started on cefepime, metronidazole,  iv vancomycin.  CRX showed diffuse pulmonary opacities appears to be moderate pulmonary edema, heart appears enlarged.  CT chest cardiomegaly,  bilateral infiltrates with consolidation at lung bases.  On 4/16 US extremities -occlusive thrombus in l popliteal vein and partially occlusive thrombus in L posterior tibial vein.  Echocardiogram -large pulmonary embolism in pulmonary artery. Vascular surgery was consulted to place a hemodialysis catheter (prior to alteplase administration).  Patient went into cardiopulmonary arrest as this procedure was started.  Patient was intubated, ACLS protocol followed, alteplase 50mg x 2 administered.  Patient expired.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ecchymosis, Full blood count, Haemoglobin normal, Immune thrombocytopenia, Petechiae
Clinical narrative: Bruising and Petechiae Critically Low platelet count
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Platelet count decreased, Thrombocytopenia, White blood cell count normal
Clinical narrative: Bruising and Petechiae Critically Low platelet count
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Contusion, Full blood count, Petechiae, Platelet count decreased
Clinical narrative: Bruising and Petechiae Critically Low platelet count
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac monitoring, Computerised tomogram head abnormal, Echocardiogram, Eye haemorrhage, Headache
Clinical narrative: TIA after the shot
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Ischaemic stroke, Magnetic resonance imaging head abnormal, Mental impairment, Muscular weakness
Clinical narrative: TIA after the shot
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Slow speech
Clinical narrative: TIA after the shot
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: TIA after the shot
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Contusion, Platelet count decreased, Thrombocytopenia
Clinical narrative: Patient developed bruise at injection site following first dose of Pfizer Covid vaccine 4/7/21.  She then developed bruise on her thigh.  She was seen at clinic on 4/15/21, CBC done - platelets 10,000.  Was sent to ER and admitted to Hospital, platelets 27,000 upon admission.  Kept for 2 days, hematology consult, labwork done, sent home with parent to permanent home out of state on 4/17/21 with stable platelet level.  Advised to retest 4/19/21 - platelet level 16,000 outpatient - was sent to ER, and was discharged home without admission.  Seeking follow up with hematologist.  No other symptoms, bruises still there but no new bruises or bleeding or other concerns.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood potassium, Blood smear test, Contusion, Full blood count, Injection site bruising
Clinical narrative: Patient developed bruise at injection site following first dose of Pfizer Covid vaccine 4/7/21.  She then developed bruise on her thigh.  She was seen at clinic on 4/15/21, CBC done - platelets 10,000.  Was sent to ER and admitted to Hospital, platelets 27,000 upon admission.  Kept for 2 days, hematology consult, labwork done, sent home with parent to permanent home out of state on 4/17/21 with stable platelet level.  Advised to retest 4/19/21 - platelet level 16,000 outpatient - was sent to ER, and was discharged home without admission.  Seeking follow up with hematologist.  No other symptoms, bruises still there but no new bruises or bleeding or other concerns.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, Pathology test, Platelet count decreased, Urine analysis
Clinical narrative: Patient developed bruise at injection site following first dose of Pfizer Covid vaccine 4/7/21.  She then developed bruise on her thigh.  She was seen at clinic on 4/15/21, CBC done - platelets 10,000.  Was sent to ER and admitted to Hospital, platelets 27,000 upon admission.  Kept for 2 days, hematology consult, labwork done, sent home with parent to permanent home out of state on 4/17/21 with stable platelet level.  Advised to retest 4/19/21 - platelet level 16,000 outpatient - was sent to ER, and was discharged home without admission.  Seeking follow up with hematologist.  No other symptoms, bruises still there but no new bruises or bleeding or other concerns.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral congestion, Cerebral haematoma, Cerebral haemorrhage, Cerebral mass effect, Cerebral venous sinus thrombosis
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Jugular vein thrombosis, Mastoid effusion, Musculoskeletal stiffness, Nausea
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Vasogenic cerebral oedema, Venogram abnormal, Vision blurred, Vomiting
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Cerebral haemorrhage, Computerised tomogram head abnormal, Fibrin D dimer increased, Headache
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Immunoglobulin therapy, Intensive care, Jugular vein thrombosis, Magnetic resonance imaging head abnormal, Neck pain
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Superior sagittal sinus thrombosis, Thrombectomy, Transverse sinus thrombosis, Venogram abnormal
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenopia, Blood glucose increased, Blood sodium normal, Brain oedema, Breast feeding
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head abnormal, Fibrin D dimer increased, Haptoglobin increased, Headache, Heparin-induced thrombocytopenia test
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Nausea, Neck pain, Photophobia, Platelet count decreased
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Postpartum state, Prothrombin time shortened, Subarachnoid haemorrhage, Thrombectomy, Thrombosis
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vision blurred, White blood cell count increased
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral haemorrhage, Cerebral venous sinus thrombosis, Headache, Jugular vein thrombosis, Magnetic resonance imaging
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Nausea, Platelet count, Platelet count decreased, Venogram
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vision blurred, Vomiting
Clinical narrative: Pt had J & J vaccine on 3/23/21, and presented with a 2 week history of right sided headache and neck pain to our facility on 4/17/21, had vomiting start about 2-3 days prior to presentation in our ED.  Head CT done showed right intraparenchymal hemorrhage, then MRI/MRV done showed Right Dural sinus thrombosis in Transverse, Sagittal, and Right Internal Jugular system with right Intraparenchymal Hemorrhage.  Labs showed low platelets of 125k, elevated D Dimer, and pt was transferred to the ICU at the Medical Center emergently for treatment with IVIG, bivalrudin, hematology consultation and sinus thrombectomy
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Deafness unilateral, Dizziness
Clinical narrative: The patient had the COVID 19 vaccine on 4/11. The following day, she developed severe nonpositional vertigo and sudden deafness and tinnitus in the right ear. She went to an urgent care and was given methylprednisone dose pak and meclizine with some relief of the vertigo, however the deafness persisted. I saw her in clinic on 4/16 and obtained a hearing test which confirmed a profound sensorineural loss in the right ear. This along with the vertigo symptoms was suggestive of labyrinthine injury to the right ear. The patient was started on high dose steroids and will follow up with a repeat hearing test in 2 weeks.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Audiogram, Deafness neurosensory, Deafness unilateral, Inner ear disorder, Tinnitus
Clinical narrative: The patient had the COVID 19 vaccine on 4/11. The following day, she developed severe nonpositional vertigo and sudden deafness and tinnitus in the right ear. She went to an urgent care and was given methylprednisone dose pak and meclizine with some relief of the vertigo, however the deafness persisted. I saw her in clinic on 4/16 and obtained a hearing test which confirmed a profound sensorineural loss in the right ear. This along with the vertigo symptoms was suggestive of labyrinthine injury to the right ear. The patient was started on high dose steroids and will follow up with a repeat hearing test in 2 weeks.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: The patient had the COVID 19 vaccine on 4/11. The following day, she developed severe nonpositional vertigo and sudden deafness and tinnitus in the right ear. She went to an urgent care and was given methylprednisone dose pak and meclizine with some relief of the vertigo, however the deafness persisted. I saw her in clinic on 4/16 and obtained a hearing test which confirmed a profound sensorineural loss in the right ear. This along with the vertigo symptoms was suggestive of labyrinthine injury to the right ear. The patient was started on high dose steroids and will follow up with a repeat hearing test in 2 weeks.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Death, Thrombosis
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Anxiety, Areflexia, Blood sodium increased, Brain herniation, Cerebral haemorrhage
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral mass effect, Coma scale abnormal, Computerised tomogram head abnormal, Computerised tomogram head normal, Condition aggravated
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Headache, Migraine, Nausea, Photophobia
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Pupil fixed, Seizure, Subarachnoid haemorrhage, Unresponsive to stimuli
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Venogram normal, Vomiting
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Adverse event
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Blood fibrinogen, Blood sodium, Cerebral haemorrhage, Cerebral venous sinus thrombosis
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Coma scale, Computerised tomogram head, Fibrin D dimer, Headache, Heparin-induced thrombocytopenia test
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Hypernatraemia, International normalised ratio, Laboratory test, Loss of consciousness, Photophobia
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count, Prophylaxis of nausea and vomiting, SARS-CoV-2 test, Seizure, Thrombocytopenia
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Venogram
Clinical narrative: Patient reported deceased 4/18/21 due to reported blood clot
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Contusion, Factor VIII inhibition, Fall, Peripheral swelling, Spontaneous haemorrhage
Clinical narrative: 2/12/21 Dose #1 COVID vaccine moderna -> 2/14/21 hematoma R arm 3/12/21 Dose #2 COVID vaccine moderna  admitted 3/17-04/01/21 with new diagnosis of acquired factor 8 inhibitor, symptomatic anemia, hematomas
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time prolonged, Anaemia, Anti factor VIII antibody increased, Anti factor VIII antibody positive, Factor V deficiency
Clinical narrative: 2/12/21 Dose #1 COVID vaccine moderna -> 2/14/21 hematoma R arm 3/12/21 Dose #2 COVID vaccine moderna  admitted 3/17-04/01/21 with new diagnosis of acquired factor 8 inhibitor, symptomatic anemia, hematomas
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haematoma
Clinical narrative: 2/12/21 Dose #1 COVID vaccine moderna -> 2/14/21 hematoma R arm 3/12/21 Dose #2 COVID vaccine moderna  admitted 3/17-04/01/21 with new diagnosis of acquired factor 8 inhibitor, symptomatic anemia, hematomas
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Angiogram pulmonary abnormal, Cerebrovascular accident, Chest X-ray abnormal, Computerised tomogram head
Clinical narrative: Patient presented to the ED 4/16- 6 days after receiving Johnson & Johnson Covid vaccine. Found to have acute CVA & bilateral PE?s. Approx 1 week after vaccine flew to another country. Experienced extreme SOB in the airport prior to flight to another country requiring wheelchair transport through the airport. Husband cut trip short leaving early. Pt came straight to the ED from the airport. During admission Neuro, Hem/Onc, & Pulm consulted. Pulm note states concern for relation to J&J vaccine. Plan to repeat CTA chest in 2-3 months.4/19. Pt d/c home to self care. On room air. New rx Eliquis.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax, Dyspnoea, Echocardiogram, Fatigue, Headache
Clinical narrative: Patient presented to the ED 4/16- 6 days after receiving Johnson & Johnson Covid vaccine. Found to have acute CVA & bilateral PE?s. Approx 1 week after vaccine flew to another country. Experienced extreme SOB in the airport prior to flight to another country requiring wheelchair transport through the airport. Husband cut trip short leaving early. Pt came straight to the ED from the airport. During admission Neuro, Hem/Onc, & Pulm consulted. Pulm note states concern for relation to J&J vaccine. Plan to repeat CTA chest in 2-3 months.4/19. Pt d/c home to self care. On room air. New rx Eliquis.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head, Scan with contrast abnormal, Thrombosis, Ultrasound Doppler, Ultrasound Doppler normal
Clinical narrative: Patient presented to the ED 4/16- 6 days after receiving Johnson & Johnson Covid vaccine. Found to have acute CVA & bilateral PE?s. Approx 1 week after vaccine flew to another country. Experienced extreme SOB in the airport prior to flight to another country requiring wheelchair transport through the airport. Husband cut trip short leaving early. Pt came straight to the ED from the airport. During admission Neuro, Hem/Onc, & Pulm consulted. Pulm note states concern for relation to J&J vaccine. Plan to repeat CTA chest in 2-3 months.4/19. Pt d/c home to self care. On room air. New rx Eliquis.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Visual impairment
Clinical narrative: Patient presented to the ED 4/16- 6 days after receiving Johnson & Johnson Covid vaccine. Found to have acute CVA & bilateral PE?s. Approx 1 week after vaccine flew to another country. Experienced extreme SOB in the airport prior to flight to another country requiring wheelchair transport through the airport. Husband cut trip short leaving early. Pt came straight to the ED from the airport. During admission Neuro, Hem/Onc, & Pulm consulted. Pulm note states concern for relation to J&J vaccine. Plan to repeat CTA chest in 2-3 months.4/19. Pt d/c home to self care. On room air. New rx Eliquis.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Cerebrovascular accident, Dyspnoea, Pulmonary embolism
Clinical narrative: Patient presented to the ED 4/16- 6 days after receiving Johnson & Johnson Covid vaccine. Found to have acute CVA & bilateral PE?s. Approx 1 week after vaccine flew to another country. Experienced extreme SOB in the airport prior to flight to another country requiring wheelchair transport through the airport. Husband cut trip short leaving early. Pt came straight to the ED from the airport. During admission Neuro, Hem/Onc, & Pulm consulted. Pulm note states concern for relation to J&J vaccine. Plan to repeat CTA chest in 2-3 months.4/19. Pt d/c home to self care. On room air. New rx Eliquis.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypersensitivity, Throat tightness
Clinical narrative: 61y F hx HLD presenting with concern for allergic reaction after Moderna covid-19 vaccine             - received 1st dose Moderna vaccine on 4/17 at Pharmacy at around 12:40pm states that within 10-12 minutes developed a headache that resolved spontaneously            - Then she felt like her throat was sore and tongue was swelling. Difficult to tell if it was hard to breathe because she says she was panicking. When she drank liquid, it made her throat feel better            - states her b/l hands swelled and turned purple            - went to ED shortly after, received IV benadryl, and all symptoms improved. ED records reviewed- normal examination, including oropharygeal and lung exam. D/c on benadryl only, no epi-pen or steroids            - since d/c from ED she has been taking Benadryl 50mg about 3 times day. Last dose this morning            - last episode of tongue swelling was yesterday morning. No swelling today but took benadryl as prophylactic
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Oropharyngeal pain, Panic attack, Peripheral swelling, Skin discolouration
Clinical narrative: 61y F hx HLD presenting with concern for allergic reaction after Moderna covid-19 vaccine             - received 1st dose Moderna vaccine on 4/17 at Pharmacy at around 12:40pm states that within 10-12 minutes developed a headache that resolved spontaneously            - Then she felt like her throat was sore and tongue was swelling. Difficult to tell if it was hard to breathe because she says she was panicking. When she drank liquid, it made her throat feel better            - states her b/l hands swelled and turned purple            - went to ED shortly after, received IV benadryl, and all symptoms improved. ED records reviewed- normal examination, including oropharygeal and lung exam. D/c on benadryl only, no epi-pen or steroids            - since d/c from ED she has been taking Benadryl 50mg about 3 times day. Last dose this morning            - last episode of tongue swelling was yesterday morning. No swelling today but took benadryl as prophylactic
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue
Clinical narrative: 61y F hx HLD presenting with concern for allergic reaction after Moderna covid-19 vaccine             - received 1st dose Moderna vaccine on 4/17 at Pharmacy at around 12:40pm states that within 10-12 minutes developed a headache that resolved spontaneously            - Then she felt like her throat was sore and tongue was swelling. Difficult to tell if it was hard to breathe because she says she was panicking. When she drank liquid, it made her throat feel better            - states her b/l hands swelled and turned purple            - went to ED shortly after, received IV benadryl, and all symptoms improved. ED records reviewed- normal examination, including oropharygeal and lung exam. D/c on benadryl only, no epi-pen or steroids            - since d/c from ED she has been taking Benadryl 50mg about 3 times day. Last dose this morning            - last episode of tongue swelling was yesterday morning. No swelling today but took benadryl as prophylactic
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time prolonged, Blood fibrinogen decreased, Blood lactate dehydrogenase decreased, Blood smear test abnormal, Computerised tomogram head abnormal
Clinical narrative: Patient presents with a 3-day history of headaches that began 4/14. Patient received the Johnson and Johnson vaccine on 4/7. She also describes cold sweats, fevers, chills, and body aches.  Her initial platelets were 27k, and their recommendations were to maintain platelets > 100k. She received a total of 5 packs of platelets overnight initially. Her neurologic function remained intact, with mainly complaints of headaches. Her platelets continued to trend down. A ROTEM and she was also noted to have low fibrinogen, so she was transfused 2 units of cryoprecipitate and 1 unit of FFP. An abdominal ultrasound showed no splenomegaly, mild hepatomegaly, and normal  liver function panel. Her urine output remained steady and she showed no signs of worsening kidney function. A blood smear did not reveal schistocytes. Her hemoglobin remained stable. At this point, heme-onc was involved and she received a dose of IVIG and started on high dose dexamethasone.  Nephrology was initially consulted early on due to concerns for thrombotic thrombocytopenic purpura, but this was ruled down on the differential. Her platelets remained low, under 20k. A lower duplex ultrasound revealed bilateral DVTs extending to her popliteal veins. Patient was transferred to a higher level hospital for continued treatment. At hospital course complicated by worsening thrombocytopenia (PLT as low as 7K) concern for thrombotic thrombocytopenic purpura requiring dexamethasone and IVIG administration. Ultrasound reveals thromboses from the popliteal vein down.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dermoid cyst, Fibrin D dimer increased, Haptoglobin, Headache, Hepatic lesion
Clinical narrative: Patient presents with a 3-day history of headaches that began 4/14. Patient received the Johnson and Johnson vaccine on 4/7. She also describes cold sweats, fevers, chills, and body aches.  Her initial platelets were 27k, and their recommendations were to maintain platelets > 100k. She received a total of 5 packs of platelets overnight initially. Her neurologic function remained intact, with mainly complaints of headaches. Her platelets continued to trend down. A ROTEM and she was also noted to have low fibrinogen, so she was transfused 2 units of cryoprecipitate and 1 unit of FFP. An abdominal ultrasound showed no splenomegaly, mild hepatomegaly, and normal  liver function panel. Her urine output remained steady and she showed no signs of worsening kidney function. A blood smear did not reveal schistocytes. Her hemoglobin remained stable. At this point, heme-onc was involved and she received a dose of IVIG and started on high dose dexamethasone.  Nephrology was initially consulted early on due to concerns for thrombotic thrombocytopenic purpura, but this was ruled down on the differential. Her platelets remained low, under 20k. A lower duplex ultrasound revealed bilateral DVTs extending to her popliteal veins. Patient was transferred to a higher level hospital for continued treatment. At hospital course complicated by worsening thrombocytopenia (PLT as low as 7K) concern for thrombotic thrombocytopenic purpura requiring dexamethasone and IVIG administration. Ultrasound reveals thromboses from the popliteal vein down.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hepatomegaly, Immune thrombocytopenia, Immunoglobulin therapy, International normalised ratio normal, Liver function test normal
Clinical narrative: Patient presents with a 3-day history of headaches that began 4/14. Patient received the Johnson and Johnson vaccine on 4/7. She also describes cold sweats, fevers, chills, and body aches.  Her initial platelets were 27k, and their recommendations were to maintain platelets > 100k. She received a total of 5 packs of platelets overnight initially. Her neurologic function remained intact, with mainly complaints of headaches. Her platelets continued to trend down. A ROTEM and she was also noted to have low fibrinogen, so she was transfused 2 units of cryoprecipitate and 1 unit of FFP. An abdominal ultrasound showed no splenomegaly, mild hepatomegaly, and normal  liver function panel. Her urine output remained steady and she showed no signs of worsening kidney function. A blood smear did not reveal schistocytes. Her hemoglobin remained stable. At this point, heme-onc was involved and she received a dose of IVIG and started on high dose dexamethasone.  Nephrology was initially consulted early on due to concerns for thrombotic thrombocytopenic purpura, but this was ruled down on the differential. Her platelets remained low, under 20k. A lower duplex ultrasound revealed bilateral DVTs extending to her popliteal veins. Patient was transferred to a higher level hospital for continued treatment. At hospital course complicated by worsening thrombocytopenia (PLT as low as 7K) concern for thrombotic thrombocytopenic purpura requiring dexamethasone and IVIG administration. Ultrasound reveals thromboses from the popliteal vein down.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Prothrombin time shortened, Pyrexia, Thrombocytopenia, Ultrasound abdomen abnormal
Clinical narrative: Patient presents with a 3-day history of headaches that began 4/14. Patient received the Johnson and Johnson vaccine on 4/7. She also describes cold sweats, fevers, chills, and body aches.  Her initial platelets were 27k, and their recommendations were to maintain platelets > 100k. She received a total of 5 packs of platelets overnight initially. Her neurologic function remained intact, with mainly complaints of headaches. Her platelets continued to trend down. A ROTEM and she was also noted to have low fibrinogen, so she was transfused 2 units of cryoprecipitate and 1 unit of FFP. An abdominal ultrasound showed no splenomegaly, mild hepatomegaly, and normal  liver function panel. Her urine output remained steady and she showed no signs of worsening kidney function. A blood smear did not reveal schistocytes. Her hemoglobin remained stable. At this point, heme-onc was involved and she received a dose of IVIG and started on high dose dexamethasone.  Nephrology was initially consulted early on due to concerns for thrombotic thrombocytopenic purpura, but this was ruled down on the differential. Her platelets remained low, under 20k. A lower duplex ultrasound revealed bilateral DVTs extending to her popliteal veins. Patient was transferred to a higher level hospital for continued treatment. At hospital course complicated by worsening thrombocytopenia (PLT as low as 7K) concern for thrombotic thrombocytopenic purpura requiring dexamethasone and IVIG administration. Ultrasound reveals thromboses from the popliteal vein down.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood fibrinogen decreased, Blood smear test normal, Chills, Cold sweat, Deep vein thrombosis
Clinical narrative: Patient presents with a 3-day history of headaches that began 4/14. Patient received the Johnson and Johnson vaccine on 4/7. She also describes cold sweats, fevers, chills, and body aches.  Her initial platelets were 27k, and their recommendations were to maintain platelets > 100k. She received a total of 5 packs of platelets overnight initially. Her neurologic function remained intact, with mainly complaints of headaches. Her platelets continued to trend down. A ROTEM and she was also noted to have low fibrinogen, so she was transfused 2 units of cryoprecipitate and 1 unit of FFP. An abdominal ultrasound showed no splenomegaly, mild hepatomegaly, and normal  liver function panel. Her urine output remained steady and she showed no signs of worsening kidney function. A blood smear did not reveal schistocytes. Her hemoglobin remained stable. At this point, heme-onc was involved and she received a dose of IVIG and started on high dose dexamethasone.  Nephrology was initially consulted early on due to concerns for thrombotic thrombocytopenic purpura, but this was ruled down on the differential. Her platelets remained low, under 20k. A lower duplex ultrasound revealed bilateral DVTs extending to her popliteal veins. Patient was transferred to a higher level hospital for continued treatment. At hospital course complicated by worsening thrombocytopenia (PLT as low as 7K) concern for thrombotic thrombocytopenic purpura requiring dexamethasone and IVIG administration. Ultrasound reveals thromboses from the popliteal vein down.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Hepatomegaly, Immunoglobulin therapy, Liver function test normal, Pain
Clinical narrative: Patient presents with a 3-day history of headaches that began 4/14. Patient received the Johnson and Johnson vaccine on 4/7. She also describes cold sweats, fevers, chills, and body aches.  Her initial platelets were 27k, and their recommendations were to maintain platelets > 100k. She received a total of 5 packs of platelets overnight initially. Her neurologic function remained intact, with mainly complaints of headaches. Her platelets continued to trend down. A ROTEM and she was also noted to have low fibrinogen, so she was transfused 2 units of cryoprecipitate and 1 unit of FFP. An abdominal ultrasound showed no splenomegaly, mild hepatomegaly, and normal  liver function panel. Her urine output remained steady and she showed no signs of worsening kidney function. A blood smear did not reveal schistocytes. Her hemoglobin remained stable. At this point, heme-onc was involved and she received a dose of IVIG and started on high dose dexamethasone.  Nephrology was initially consulted early on due to concerns for thrombotic thrombocytopenic purpura, but this was ruled down on the differential. Her platelets remained low, under 20k. A lower duplex ultrasound revealed bilateral DVTs extending to her popliteal veins. Patient was transferred to a higher level hospital for continued treatment. At hospital course complicated by worsening thrombocytopenia (PLT as low as 7K) concern for thrombotic thrombocytopenic purpura requiring dexamethasone and IVIG administration. Ultrasound reveals thromboses from the popliteal vein down.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Platelet transfusion, Pyrexia, Ultrasound abdomen abnormal, Ultrasound scan abnormal
Clinical narrative: Patient presents with a 3-day history of headaches that began 4/14. Patient received the Johnson and Johnson vaccine on 4/7. She also describes cold sweats, fevers, chills, and body aches.  Her initial platelets were 27k, and their recommendations were to maintain platelets > 100k. She received a total of 5 packs of platelets overnight initially. Her neurologic function remained intact, with mainly complaints of headaches. Her platelets continued to trend down. A ROTEM and she was also noted to have low fibrinogen, so she was transfused 2 units of cryoprecipitate and 1 unit of FFP. An abdominal ultrasound showed no splenomegaly, mild hepatomegaly, and normal  liver function panel. Her urine output remained steady and she showed no signs of worsening kidney function. A blood smear did not reveal schistocytes. Her hemoglobin remained stable. At this point, heme-onc was involved and she received a dose of IVIG and started on high dose dexamethasone.  Nephrology was initially consulted early on due to concerns for thrombotic thrombocytopenic purpura, but this was ruled down on the differential. Her platelets remained low, under 20k. A lower duplex ultrasound revealed bilateral DVTs extending to her popliteal veins. Patient was transferred to a higher level hospital for continued treatment. At hospital course complicated by worsening thrombocytopenia (PLT as low as 7K) concern for thrombotic thrombocytopenic purpura requiring dexamethasone and IVIG administration. Ultrasound reveals thromboses from the popliteal vein down.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Body temperature, Chills, Gait disturbance, Headache
Clinical narrative: Patient presents with a 3-day history of headaches that began 4/14. Patient received the Johnson and Johnson vaccine on 4/7. She also describes cold sweats, fevers, chills, and body aches.  Her initial platelets were 27k, and their recommendations were to maintain platelets > 100k. She received a total of 5 packs of platelets overnight initially. Her neurologic function remained intact, with mainly complaints of headaches. Her platelets continued to trend down. A ROTEM and she was also noted to have low fibrinogen, so she was transfused 2 units of cryoprecipitate and 1 unit of FFP. An abdominal ultrasound showed no splenomegaly, mild hepatomegaly, and normal  liver function panel. Her urine output remained steady and she showed no signs of worsening kidney function. A blood smear did not reveal schistocytes. Her hemoglobin remained stable. At this point, heme-onc was involved and she received a dose of IVIG and started on high dose dexamethasone.  Nephrology was initially consulted early on due to concerns for thrombotic thrombocytopenic purpura, but this was ruled down on the differential. Her platelets remained low, under 20k. A lower duplex ultrasound revealed bilateral DVTs extending to her popliteal veins. Patient was transferred to a higher level hospital for continued treatment. At hospital course complicated by worsening thrombocytopenia (PLT as low as 7K) concern for thrombotic thrombocytopenic purpura requiring dexamethasone and IVIG administration. Ultrasound reveals thromboses from the popliteal vein down.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscle spasms, Pain in extremity, Platelet count, Platelet count decreased, Pyrexia
Clinical narrative: Patient presents with a 3-day history of headaches that began 4/14. Patient received the Johnson and Johnson vaccine on 4/7. She also describes cold sweats, fevers, chills, and body aches.  Her initial platelets were 27k, and their recommendations were to maintain platelets > 100k. She received a total of 5 packs of platelets overnight initially. Her neurologic function remained intact, with mainly complaints of headaches. Her platelets continued to trend down. A ROTEM and she was also noted to have low fibrinogen, so she was transfused 2 units of cryoprecipitate and 1 unit of FFP. An abdominal ultrasound showed no splenomegaly, mild hepatomegaly, and normal  liver function panel. Her urine output remained steady and she showed no signs of worsening kidney function. A blood smear did not reveal schistocytes. Her hemoglobin remained stable. At this point, heme-onc was involved and she received a dose of IVIG and started on high dose dexamethasone.  Nephrology was initially consulted early on due to concerns for thrombotic thrombocytopenic purpura, but this was ruled down on the differential. Her platelets remained low, under 20k. A lower duplex ultrasound revealed bilateral DVTs extending to her popliteal veins. Patient was transferred to a higher level hospital for continued treatment. At hospital course complicated by worsening thrombocytopenia (PLT as low as 7K) concern for thrombotic thrombocytopenic purpura requiring dexamethasone and IVIG administration. Ultrasound reveals thromboses from the popliteal vein down.